Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples